Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Sickle Cell Disease Visiting Professorship ProgramRelease Date:Education Rare Disease USA Initiatives for Healthcare Professionals to Promote Intramuscular Vaccination Methods for ChildrenRelease Date:Quality Improvement Vaccines Japan Efforts to Improve Quality of Migraine Medical CareRelease Date:Partner: The Japanese Headache SocietyQuality Improvement Internal Medicine Japan Improving Vaccination Systems and Environments to Promote prevention of Respiratory Infections in Older AdultsRelease Date:Quality Improvement Vaccines Japan Optimizing the Experience of Patients with Bladder Cancer Through Multi-Disciplinary CareRelease Date:Partner: Conquer Cancer, the ASCO FoundationQuality Improvement Oncology USA The Enhancement of Management of breast cancer in French speaking Sub-Saharan African CountriesRelease Date:Partner: AMFROMQuality Improvement Oncology Benin, Congo, The Democratic Republic, Mali, Senegal, Togo Clinical Updates and Strategies in the Treatment and Management of First-line BRAF V600E-mutant Metastatic Colorectal CancerRelease Date:Education Oncology USA Guidelines and Best Practices in the Holistic Management of Patients with Metastatic Urothelial Carcinoma (mUC)Education Oncology USA Post-COVID Conditions: Potential Diagnosis, Testing, Management, and Ongoing ResearchRelease Date:Education Vaccines USA COVID-19 Disease Burden on the Pediatric PopulationRelease Date:Education Vaccines USA Improving Atopic Dermatitis and Alopecia Areata Quality of Care to Standardize ManagementRelease Date:Partner: Beijing Guangda Precision Medicine Research CenterQuality Improvement Inflammation & Immunology China Title Grant Type Focus Area Country Application Due Date Growth Hormone ResearchRelease Date:Research Rare Disease USA Efforts for early detection of atrial fibrillation and cardioembolic stroke preventionRelease Date:Quality Improvement Internal Medicine Japan Preventing cardiovascular diseases such as venous thromboembolism in cancer patients by raising awareness and promoting medicalRelease Date:Education Internal Medicine Japan Patient Registries In ATTR-CMRelease Date:Quality Improvement Rare Disease Japan Optimizing Menopausal Symptom Management in CanadaRelease Date:Quality Improvement Internal Medicine Canada Optimizing Menopausal Symptom Management in CanadaRelease Date:Quality Improvement Internal Medicine Canada Gene and Anti-TFPI Therapies in HemophiliaRelease Date:Research Rare Disease All Implementing Updated Pneumococcal Immunization Recommendations in AdultsRelease Date:Quality Improvement Vaccines USA Employment support / Lung CancerRelease Date:Education Oncology Japan Biomarker Testing / Lung CancerRelease Date:Education Oncology Japan Cachexia in Cancer – Educational Needs Assessment (USA, Canada, Japan, Italy, UK, Spain, Germany, France)Release Date:Education Internal Medicine Canada, France, Germany, Italy, Japan, Spain, USA, United Kingdom Addressing Knowledge Gaps in the Care of Patients with HR-positive/HER2-negative Advanced Breast CancerRelease Date:Education Oncology Japan